Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: A case report and hypothesis of neuroendocrine tumor development

Pathology International

Volumn 62, Issue 5, 2012, Pages 331-334

  Miura, Katsutoshi ^a   Nasu, Hatsuko ^a   Ogura, Hiroyuki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast neoplasm; Ductal carcinoma in situ; Neuroendocrine cell tumor; Somatostatin receptor

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN A; MUCIN; SOMATOSTATIN RECEPTOR 2; SYNAPTOPHYSIN;

AGED; ARTICLE; BREAST ATROPHY; CARCINOGENESIS; CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DOUBLE NEUROENDOCRINE DUCTAL CARCINOM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; NEUROENDOCRINE BREAST CELL HYPREPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

AGED; ANTIGENS, CD56; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, NEUROENDOCRINE; CHROMOGRANIN A; FEMALE; HUMANS; HYPERPLASIA; NEOPLASMS, MULTIPLE PRIMARY; NEUROSECRETORY SYSTEMS; RECEPTORS, SOMATOSTATIN; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84860308405     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02786.x     Document Type: Article

References (18)

1. Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC, 2003.
2. Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA. Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep 2008; 20: 1369-74.
3. Kawasaki T, Nakamura S, Sakamoto G etal. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast-comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases. Histopathology 2008; 53: 288-98.
4. Satake T, Matsuyama M. Endocrine cells in a normal breast and non-cancerous breast lesion. Acta Pathol Jpn 1991; 41: 874-78.
5. Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ('carcinoids') and normal tissue of the breast. Am J Pathol 1985; 120: 186-92.
6. Nesland J, Lunde S, Holm R, Johannessen J. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells. Histol Histopathol 1987; 2: 73-7.
7. Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: A form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996; 20: 921-43.
8. Travis W, Brambilla E, Muller-Hermelink H, Harris C, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC, 2004.
9. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg 1996; 20: 168-72.
10. Bosman F, Carneiro F, Hruban R, Theise N, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC, 2010.
11. Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007; 21: 15-31.
12. Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 2006; 30: 501-7.
13. Otsuki Y, Yamada M, Shimizu S etal. Solid-papillary carcinoma of the breast: Clinicopathological study of 20 cases. Pathol Int 2007; 57: 421-9.
14. Tavassoli FA, Eusebi V, eds. Tumors of the Mammary Gland. Washington, DC: American registry of pathology, 2009.
15. Honami H, Sotome K, Sakamoto G etal. Synchronous bilateral neuroendocrine ductal carcinoma in situ. Breast Cancer 2011; (Epub ahead of print).
16. Papotti M, Macrí L, Bussolati G, Reubi JC. Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int J Cancer 1989; 43: 365-9.
17. Oberg K. Cancer: Antitumor effects of octreotide LAR, a somatostatin analog. Nat Rev Endocrinol 2010; 6: 188-9.
18. Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Gastroenterology 2010; 139: 742-53.